Literature DB >> 23680145

Tumor cell dissemination: emerging biological insights from animal models and cancer patients.

Yibin Kang1, Klaus Pantel.   

Abstract

Circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) are increasingly recognized for their potential utility in disease monitoring and therapeutic targeting. The clinical application of CTC/DTC requires better understanding of the biological mechanisms behind tumor dissemination, the survival of DTCs, and their activation to aggressive growth from dormancy. Recent research using animal models of DTCs and CTCs have provided novel insights into these processes. Here, we discuss these findings in the context of results obtained from the clinical analyses of CTCs and DTCs, which demonstrate that the animal models mimic, in many aspects, the complex situation in patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23680145      PMCID: PMC3667710          DOI: 10.1016/j.ccr.2013.04.017

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  105 in total

1.  Snail blocks the cell cycle and confers resistance to cell death.

Authors:  Sonia Vega; Aixa V Morales; Oscar H Ocaña; Francisco Valdés; Isabel Fabregat; M Angela Nieto
Journal:  Genes Dev       Date:  2004-05-15       Impact factor: 11.361

Review 2.  Dissecting the metastatic cascade.

Authors:  Klaus Pantel; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

3.  Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.

Authors:  A J van de Wouw; M L G Janssen-Heijnen; J W W Coebergh; H F P Hillen
Journal:  Eur J Cancer       Date:  2002-02       Impact factor: 9.162

4.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Authors:  Jeff H Tsai; Joana Liu Donaher; Danielle A Murphy; Sandra Chau; Jing Yang
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

5.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

6.  Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.

Authors:  S Braun; C Kentenich; W Janni; F Hepp; J de Waal; F Willgeroth; H Sommer; K Pantel
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

7.  Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.

Authors:  T Brabletz; A Jung; S Reu; M Porzner; F Hlubek; L A Kunz-Schughart; R Knuechel; T Kirchner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 8.  Circulating tumor cells: liquid biopsy of cancer.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Clin Chem       Date:  2012-09-26       Impact factor: 8.327

9.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency.

Authors:  M D Cameron; E E Schmidt; N Kerkvliet; K V Nadkarni; V L Morris; A C Groom; A F Chambers; I C MacDonald
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

10.  Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

Authors:  Christin Gasch; Thomas Bauernhofer; Martin Pichler; Sabine Langer-Freitag; Matthias Reeh; Adrian M Seifert; Oliver Mauermann; Jakob R Izbicki; Klaus Pantel; Sabine Riethdorf
Journal:  Clin Chem       Date:  2012-11-07       Impact factor: 8.327

View more
  171 in total

1.  Macromolecular crowding tunes 3D collagen architecture and cell morphogenesis.

Authors:  S K Ranamukhaarachchi; R N Modi; A Han; D O Velez; A Kumar; A J Engler; S I Fraley
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

Review 2.  Challenges in circulating tumour cell research.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2014-07-31       Impact factor: 60.716

Review 3.  Bone metastasis and the metastatic niche.

Authors:  Guangwen Ren; Mark Esposito; Yibin Kang
Journal:  J Mol Med (Berl)       Date:  2015-08-15       Impact factor: 4.599

Review 4.  Mechanisms governing metastatic dormancy and reactivation.

Authors:  Filippo G Giancotti
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

5.  2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

Authors:  Dayong Zheng; Xing Chang; Yang Liu; Jingwen Xu; Wenfeng Gou; Zengqiang Li; Daiying Zuo; Weige Zhang; Yingliang Wu
Journal:  Cancer Biol Ther       Date:  2018-12-04       Impact factor: 4.742

Review 6.  Tumour microenvironment: informing on minimal residual disease in solid tumours.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

7.  Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients.

Authors:  Xiaohui Ni; Minglei Zhuo; Zhe Su; Jianchun Duan; Yan Gao; Zhijie Wang; Chenghang Zong; Hua Bai; Alec R Chapman; Jun Zhao; Liya Xu; Tongtong An; Qi Ma; Yuyan Wang; Meina Wu; Yu Sun; Shuhang Wang; Zhenxiang Li; Xiaodan Yang; Jun Yong; Xiao-Dong Su; Youyong Lu; Fan Bai; X Sunney Xie; Jie Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

8.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

9.  Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.

Authors:  M Banys-Paluchowski; H Schneck; C Blassl; S Schultz; F Meier-Stiegen; D Niederacher; N Krawczyk; E Ruckhaeberle; T Fehm; H Neubauer
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-03       Impact factor: 2.915

Review 10.  Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.

Authors:  Sumitra Mohan; Francesca Chemi; Ged Brady
Journal:  Transl Lung Cancer Res       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.